Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 2,711 · FY2022 4,488 · FY2023 6,075 — 3-yr total 13,274
Operates in Pharma — Distribution. Per the activity note to the FY2023 annual report, the company conducts wholesale and retail trade in pharmaceutical products in specialized pharmacies.
| Line item | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|
| 9,068 | 15,018 | 24,863 | 35,912 | +58.2% | |
| 2,928 | 3,967 | 4,947 | 4,784 | +17.8% | |
| TOTAL ASSETS | 11,996 | 18,984 | 29,810 | 40,696 | +50.3% |
| 963 | 2,275 | 1,550 | 6,368 | +87.7% | |
| Total Non-Current Liabilities | 170 | 380 | 106 | 0 | nmf |
| TOTAL LIABILITIES | 1,133 | 2,655 | 1,655 | 6,368 | +77.8% |
| 10,863 | 16,329 | 28,155 | 34,329 | +46.7% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||
| Total Debt | 0 | 2,209 | 0 | 4,034 | +35.1% |
| Cash & Equivalents | 491 | 5,330 | 4,982 | 12,797 | +196.6% |
| Net Debt | 491 | 3,121 | 4,982 | 8,763 | +161.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →